Skip to main content
. 2016 Sep 30;38(5):1433–1442. doi: 10.3892/ijmm.2016.2763

Figure 6.

Figure 6

Schematic diagram of the mechanisms through which rolipram (ROL) attenuates pain behavior in bone cancer pain. TNFR1, tumor necrosis factor receptor 1.